Various measures of rate and extent of absorption in bioequivalent study of norfloxacin tablet

O. Y.P. Hu, T. M. Hu, B. L. Chen, K. M. Chu

Research output: Contribution to journalArticle

Abstract

Various measures of rate and extent of absorption were reported recently for bioequivalence study. Besides the widely used parameters, AUC(∞), C(max), LnAUC(∞) and LnC(max), partial AUC such as AUP(p), AUC1, AUC2 AUC3, combination parameters, C(max)/AUC(t(max)) and C(max)/t(max), were used. Other parameters using concentrations at specific times to the t(max) of the reference product were also applied. Comparison of the measurements between two norfloxacin tablet was selected as an example. Norfloxacin tablets were manufactured by two different pharmaceutical factories (Baccidal, Kyorin, Japan; Norfloxacin, Kingdom Taiwan, R.O.C.). A single oral 400 mg (4* 100 mg/tab) dose of Baccidal and Norfloxacin was administered in 12 healthy young Chinese males in a completely randomized double-blind cross-over design with a one-week wash-out period between each dose. Plasma samples were obtained before and after various appropriate intervals after dosing up to 24 hours. The plasma concentrations were then analyzed by a self-developed HPLC. The low detection limit of this HPLC method was 13 ng in plasma. The limit of quantitation was 40 ng/mL. Values for the area under the plasma concentration-time curve to time infinity (AUC(∞)), peak concentration (C(max)), time to peak concentration (t(max)), C(max)/AUC(tmax), C(max)/t(max), partial AUC, AUC1 2, and AUC to the t(max) (AUC(t(max))), volume of distribution and oral clearance were compared for each preparation. Log transformation of AUC(∞) and C(max) were also performed for comparison. Intra- and intersubject variations were checked by comparing apparent volume of distribution and oral clearance. All the parameters were not significantly different based on the results of ANOVA. By using power analysis and 90% confidence interval, we can conclude that Baccidal and Norfloxacin are bioequivalent. Among various measures of rate and extent of absorption, AUC12, C(max)/AUC(∞) had the same results with LnAUC(∞) and LnC(max). However, AUC(t(max)), C(max)/AUC(t(max)), and C(max)/t(max) had different results with the commonly used bioequivalent parameters. The meaning of each parameter is discussed in detail.

Original languageEnglish
Pages (from-to)363-376
Number of pages14
JournalChinese Pharmaceutical Journal
Volume47
Issue number4
Publication statusPublished - Nov 3 1995
Externally publishedYes

Fingerprint

Norfloxacin
Tablets
Area Under Curve
High Pressure Liquid Chromatography
Therapeutic Equivalency
Taiwan
Cross-Over Studies

Keywords

  • bioequivalence
  • extent of absorption
  • norfloxacin
  • rate of absorption

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Various measures of rate and extent of absorption in bioequivalent study of norfloxacin tablet. / Hu, O. Y.P.; Hu, T. M.; Chen, B. L.; Chu, K. M.

In: Chinese Pharmaceutical Journal, Vol. 47, No. 4, 03.11.1995, p. 363-376.

Research output: Contribution to journalArticle

Hu, O. Y.P. ; Hu, T. M. ; Chen, B. L. ; Chu, K. M. / Various measures of rate and extent of absorption in bioequivalent study of norfloxacin tablet. In: Chinese Pharmaceutical Journal. 1995 ; Vol. 47, No. 4. pp. 363-376.
@article{99afa0c55c0e46339b012619bccbdd84,
title = "Various measures of rate and extent of absorption in bioequivalent study of norfloxacin tablet",
abstract = "Various measures of rate and extent of absorption were reported recently for bioequivalence study. Besides the widely used parameters, AUC(∞), C(max), LnAUC(∞) and LnC(max), partial AUC such as AUP(p), AUC1, AUC2 AUC3, combination parameters, C(max)/AUC(t(max)) and C(max)/t(max), were used. Other parameters using concentrations at specific times to the t(max) of the reference product were also applied. Comparison of the measurements between two norfloxacin tablet was selected as an example. Norfloxacin tablets were manufactured by two different pharmaceutical factories (Baccidal, Kyorin, Japan; Norfloxacin, Kingdom Taiwan, R.O.C.). A single oral 400 mg (4* 100 mg/tab) dose of Baccidal and Norfloxacin was administered in 12 healthy young Chinese males in a completely randomized double-blind cross-over design with a one-week wash-out period between each dose. Plasma samples were obtained before and after various appropriate intervals after dosing up to 24 hours. The plasma concentrations were then analyzed by a self-developed HPLC. The low detection limit of this HPLC method was 13 ng in plasma. The limit of quantitation was 40 ng/mL. Values for the area under the plasma concentration-time curve to time infinity (AUC(∞)), peak concentration (C(max)), time to peak concentration (t(max)), C(max)/AUC(tmax), C(max)/t(max), partial AUC, AUC1 2, and AUC to the t(max) (AUC(t(max))), volume of distribution and oral clearance were compared for each preparation. Log transformation of AUC(∞) and C(max) were also performed for comparison. Intra- and intersubject variations were checked by comparing apparent volume of distribution and oral clearance. All the parameters were not significantly different based on the results of ANOVA. By using power analysis and 90{\%} confidence interval, we can conclude that Baccidal and Norfloxacin are bioequivalent. Among various measures of rate and extent of absorption, AUC12, C(max)/AUC(∞) had the same results with LnAUC(∞) and LnC(max). However, AUC(t(max)), C(max)/AUC(t(max)), and C(max)/t(max) had different results with the commonly used bioequivalent parameters. The meaning of each parameter is discussed in detail.",
keywords = "bioequivalence, extent of absorption, norfloxacin, rate of absorption",
author = "Hu, {O. Y.P.} and Hu, {T. M.} and Chen, {B. L.} and Chu, {K. M.}",
year = "1995",
month = "11",
day = "3",
language = "English",
volume = "47",
pages = "363--376",
journal = "Taiwan Pharmaceutical Journal",
issn = "1016-1015",
publisher = "臺灣藥學會",
number = "4",

}

TY - JOUR

T1 - Various measures of rate and extent of absorption in bioequivalent study of norfloxacin tablet

AU - Hu, O. Y.P.

AU - Hu, T. M.

AU - Chen, B. L.

AU - Chu, K. M.

PY - 1995/11/3

Y1 - 1995/11/3

N2 - Various measures of rate and extent of absorption were reported recently for bioequivalence study. Besides the widely used parameters, AUC(∞), C(max), LnAUC(∞) and LnC(max), partial AUC such as AUP(p), AUC1, AUC2 AUC3, combination parameters, C(max)/AUC(t(max)) and C(max)/t(max), were used. Other parameters using concentrations at specific times to the t(max) of the reference product were also applied. Comparison of the measurements between two norfloxacin tablet was selected as an example. Norfloxacin tablets were manufactured by two different pharmaceutical factories (Baccidal, Kyorin, Japan; Norfloxacin, Kingdom Taiwan, R.O.C.). A single oral 400 mg (4* 100 mg/tab) dose of Baccidal and Norfloxacin was administered in 12 healthy young Chinese males in a completely randomized double-blind cross-over design with a one-week wash-out period between each dose. Plasma samples were obtained before and after various appropriate intervals after dosing up to 24 hours. The plasma concentrations were then analyzed by a self-developed HPLC. The low detection limit of this HPLC method was 13 ng in plasma. The limit of quantitation was 40 ng/mL. Values for the area under the plasma concentration-time curve to time infinity (AUC(∞)), peak concentration (C(max)), time to peak concentration (t(max)), C(max)/AUC(tmax), C(max)/t(max), partial AUC, AUC1 2, and AUC to the t(max) (AUC(t(max))), volume of distribution and oral clearance were compared for each preparation. Log transformation of AUC(∞) and C(max) were also performed for comparison. Intra- and intersubject variations were checked by comparing apparent volume of distribution and oral clearance. All the parameters were not significantly different based on the results of ANOVA. By using power analysis and 90% confidence interval, we can conclude that Baccidal and Norfloxacin are bioequivalent. Among various measures of rate and extent of absorption, AUC12, C(max)/AUC(∞) had the same results with LnAUC(∞) and LnC(max). However, AUC(t(max)), C(max)/AUC(t(max)), and C(max)/t(max) had different results with the commonly used bioequivalent parameters. The meaning of each parameter is discussed in detail.

AB - Various measures of rate and extent of absorption were reported recently for bioequivalence study. Besides the widely used parameters, AUC(∞), C(max), LnAUC(∞) and LnC(max), partial AUC such as AUP(p), AUC1, AUC2 AUC3, combination parameters, C(max)/AUC(t(max)) and C(max)/t(max), were used. Other parameters using concentrations at specific times to the t(max) of the reference product were also applied. Comparison of the measurements between two norfloxacin tablet was selected as an example. Norfloxacin tablets were manufactured by two different pharmaceutical factories (Baccidal, Kyorin, Japan; Norfloxacin, Kingdom Taiwan, R.O.C.). A single oral 400 mg (4* 100 mg/tab) dose of Baccidal and Norfloxacin was administered in 12 healthy young Chinese males in a completely randomized double-blind cross-over design with a one-week wash-out period between each dose. Plasma samples were obtained before and after various appropriate intervals after dosing up to 24 hours. The plasma concentrations were then analyzed by a self-developed HPLC. The low detection limit of this HPLC method was 13 ng in plasma. The limit of quantitation was 40 ng/mL. Values for the area under the plasma concentration-time curve to time infinity (AUC(∞)), peak concentration (C(max)), time to peak concentration (t(max)), C(max)/AUC(tmax), C(max)/t(max), partial AUC, AUC1 2, and AUC to the t(max) (AUC(t(max))), volume of distribution and oral clearance were compared for each preparation. Log transformation of AUC(∞) and C(max) were also performed for comparison. Intra- and intersubject variations were checked by comparing apparent volume of distribution and oral clearance. All the parameters were not significantly different based on the results of ANOVA. By using power analysis and 90% confidence interval, we can conclude that Baccidal and Norfloxacin are bioequivalent. Among various measures of rate and extent of absorption, AUC12, C(max)/AUC(∞) had the same results with LnAUC(∞) and LnC(max). However, AUC(t(max)), C(max)/AUC(t(max)), and C(max)/t(max) had different results with the commonly used bioequivalent parameters. The meaning of each parameter is discussed in detail.

KW - bioequivalence

KW - extent of absorption

KW - norfloxacin

KW - rate of absorption

UR - http://www.scopus.com/inward/record.url?scp=0028790176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028790176&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028790176

VL - 47

SP - 363

EP - 376

JO - Taiwan Pharmaceutical Journal

JF - Taiwan Pharmaceutical Journal

SN - 1016-1015

IS - 4

ER -